Table 2.

The age-adjusted prevalence of health outcomes by subjective social status ^a

Sex	Subjective social status rank										Total	Trend ^b
	1^st	2nd	3rd	4th	5^th	6th	7th	8th	9th	10^th
	Lowest									Highest
Poor/fair self-rated health
Males	70.4	58.8	52.9	36.2	28.6	25.7	19.2	15.5	16.4	8.7	25.6	p≤0.001
N	20	58	194	355	583	798	701	498	130	28	3365
Females	82.3	45.1	46.1	34.8	26.3	24.2	18.6	18.8	15.5	32.0	24.8	p≤0.001
N	26	85	201	403	850	1162	724	447	144	22	4064
Four or more depressive symptoms on an eight-item Center for Epidemiological Studies Depression (CES-D) scale
Males	50.1	41.9	27.9	13.2	10.6	8.0	8.0	6.5	4.4	0.0	9.5	p≤0.001
N	19	58	191	345	579	793	692	497	128	28	3330
Females	53.7	47.8	34.3	23.4	17.2	14.3	12.9	10.6	11.2	9.8	15.7	p≤0.001
N	25	85	196	401	842	1152	718	446	144	22	4031
Existence of long-standing illness or disability
Males	85.5	84.4	71.0	60.0	54.3	57.5	52.0	48.7	32.6	39.9	55.5	p≤0.001
N	21	58	194	356	583	799	700	497	130	28	3366
Females	89.2	72.4	71.8	60.3	59.7	54.1	53.2	51.2	47.9	39.1	56.5	p≤0.001
N	26	85	201	404	850	1160	724	447	144	22	4063
Diagnosed or measured hypertension ≥140/90mmHg
Males	73.4	64.1	74.1	66.2	63.1	59.2	59.8	58.9	44.9	64.7	61.6	p≤0.001
N	16	38	158	262	465	604	576	396	93	21	2629
Females	63.7	61.1	60.0	63.5	60.8	59.3	57.9	58.9	46.4	50.6	59.3	p=0.022
N	21	55	155	319	665	927	590	362	118	16	3328
Diagnosed diabetes or glycated haemoglobin (HbA1c) ≥ 6.0%
Males	26.7	30.2	25.2	13.9	17.0	18.2	14.4	13.4	17.7	5.5	16.6	p=0.004
N	17	37	127	227	404	556	517	362	91	21	2359
Females	23.8	21.5	17.1	14.2	10.0	8.9	10.0	8.1	7.5	0.0	10.1	p≤0.001
N	17	54	138	274	582	806	523	314	102	13	2823
Central obesity (waist circumference ≥ 94cm in men and ≥ 80cm in women)
Males	73.2	77.1	72.4	76.0	77.9	72.2	75.5	76.3	69.7	68.8	74.9	p=0.646
N	17	43	169	297	506	697	616	430	110	27	2912
Females	94.6	90.2	82.0	83.3	80.3	79.6	77.4	80.3	69.6	69.4	79.8	p≤0.001
N	20	69	170	337	739	1011	646	394	128	19	3533
HDL-cholesterol < 1 mmol/L in men and < 1.3 mmol/L in women
Males	24.2	27.7	14.3	19.3	13.6	16.8	12.7	10.4	7.9	12.0	14.3	p≤0.001
N	17	38	125	238	412	570	526	365	93	21	2405
Females	30.1	23.6	24.8	18.4	14.5	14.7	11.5	10.2	13.4	0.0	14.2	p≤0.001
N	16	54	138	278	593	812	529	316	104	13	2853
Triglycerides ≥ 1.7 mmol/L
Males	53.8	54.2	49.9	52.4	48.8	47.6	46.3	46.7	42.2	70.2	48.3	p=0.138
N	17	38	126	238	412	570	527	366	93	22	2409
Females	53.3	50.7	49.4	45.0	43.6	37.7	39.1	39.5	27.0	42.0	40.5	p≤0.001
N	16	54	138	278	592	812	529	316	104	13	2852
Log-transformed fibrinogen (g/L) ^c
Males	3.74	3.42	3.27	3.11	3.11	3.10	3.05	3.05	2.91	2.97	3.10	p≤0.001
N	17	38	126	234	409	566	523	365	91	22	2391
Females	3.11	3.39	3.37	3.27	3.22	3.24	3.15	3.15	3.11	3.17	3.21	p≤0.001
N	17	55	138	274	588	801	522	317	102	13	2827
Log-transformed C-reactive protein (mg/L) ^c,^d
Males	2.9	2.2	1.9	1.8	1.7	1.7	1.6	1.6	1.3	1.8	1.7	p≤0.001
N	11	33	116	219	378	526	492	340	90	22	2227
Females	1.3	2.0	2.2	2.1	1.9	1.8	1.7	1.6	1.2	1.5	1.8	p≤0.001
N	15	44	121	256	546	756	501	286	97	12	2634

Frequencies are weighted for non-response, while counts are not

Derived from regression analyses adjusted for age

Results are presented in the form of geometric mean

Cases with CRP>10mg/L were excluded from analysis